Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Rectal Mucositis

An inflammatory process affecting the mucous membrane of the rectum.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Objective: To evaluate the safety and preliminary efficacy of total neoadjuvant therapy (TNT) in patients with locally advanced… Expand
Is this relevant?
Review
2018
Review
2018
Radiation proctitis is radiation-induced rectal mucositis, occurring as a result of radiation therapy for various pelvic… Expand
  • figure 1
  • table 1
  • figure 2
Is this relevant?
Review
2016
Review
2016
INTRODUCTION Radiation proctitis is radiation induced rectal mucositis, occurring as a consequence to radiation therapy of the… Expand
Is this relevant?
Review
2008
Review
2008
Curative radiation therapy of pelvic malignancies, frequently results in dose-limiting toxicities such as serous, mucoid, or more… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2006
2006
PURPOSE The aim of this study was to evaluate the efficacy and tolerance of preoperative chemoradiotherapy (CRT) with irinotecan… Expand
Is this relevant?
2006
2006
Often the rectum is a dose-limiting organ in curative radiation therapy of pelvic malignancies. It results in serous, mucoid, or… Expand
Is this relevant?
2005
2005
PURPOSE To investigate the cytoprotective effect of subcutaneous vs. intrarectal administration of amifostine against acute… Expand
Is this relevant?
2004
2004
Purpose:To investigate the cytoprotective effect of intrarectal amifostine administration on acute radiation-induced rectal… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2003
2003
Aim: To evaluate the cytoprotective effect of amifostine against radiation-induced acute toxicity to the rectal mucosa. Patients… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
PURPOSE Amifostine (WR-2721) is an important cytoprotective agent. Although intravenous administration is the standard route… Expand
Is this relevant?